Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), ran... حسب Claire M. Douglas (21238238)

الموضوعات:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 2 times/week) or did not meet (< 2 times/week) WHO’s resistance traini... حسب Claire M. Douglas (21238238)

الموضوعات:

Combination of intraperitoneal and intratumoral administration of vitamin D3 is more effective in reducing the EAC tumor volume compared to just i.p. administration: حسب Vidya G. Bettada (22208808)

"…Administration of cisplatin (2.5 mg/Kg) and vitamin D3 (125 µg/Kg) significantly decreased the vessel density (CD31) compared to the tumor control group.…"

(a to g) Administration of vitamin D3 increased serum phosphorus and triglycerides. حسب Vidya G. Bettada (22208808)

"…Analyses of serum cholesterol, HDL and triglycerides also showed a non-significant decrease in the serum HDL level upon treatment with 125 µg/Kg vitamin D3, but a noticeable increase in the serum triglyceride level was observed with 125 µg/Kg of vitamin D3.…"

Treatment of cancer cells with vitamin D3 induced death <i>a.</i> حسب Vidya G. Bettada (22208808)

Expression of Caspase-3 in HCT 116 and Hep 3B: <i>2A. and 2B.</i> حسب Vidya G. Bettada (22208808)

Treatment with vitamin D3 reduced the viability of cancer cell lines: <i>1A & 1B.</i> حسب Vidya G. Bettada (22208808)

"…Mouse EAC cells showed a decrease in cell viability starting from 250 µM at 24h of treatment. …"

Vitamin D3, but not the Cisplatin, could moderately reduce STZ-induced hyperglycemia in mice (a) Schematic representation of experimental protocol followed in the study: After accl... حسب Vidya G. Bettada (22208808)

"…(c) Vitamin D3 and the positive control Cisplatin differently modulated FBG in hyperglycaemic mice: Intraperitoneal administration of vitamin D3 very minimally decreased FBG compared to vehicle control at the end of the study. …"

AO/EtBr Staining of Cancer cell lines: <i>To check whether vitamin D3 promoted cell death in cancer cells, a dual staining protocol was implemented as detailed in the methods secti... حسب Vidya G. Bettada (22208808)

The sagittal view of T2-weighted Magnetic Resonance Imaging represented a mild decrease in spinal cord diameter without any other lesions at first admission. حسب Hossein Pourmontaseri (19329565)

Comparison of serum VEGF-A165 concentrations pre-bevacizumab administration in patients with increased VEGF-A post-bevacizumab administration and those with decreased VEGF-A. حسب Masashi Okawa (8951294)

الموضوعات:

Starvation improves locomotory capacity and decreases the number of α-synuclein-YFP aggregates of transgenic <i>C. elegans</i> through LMP-1 dependent mechanism. حسب María Gallardo-Campos (22170919)

The sagittal view of T2-weighted Magnetic Resonance Imaging represented a mildly decreased spinal cord diameter without any other lesions at follow-up. حسب Hossein Pourmontaseri (19329565)

Annual incidence of insomnia disorder (ICD-CODE: G47) Bar: rate of insomnia disorder relative to all patients; Line: average number of outpatient visits for patients with insomnia... حسب Mingee Choi (15250732)

الموضوعات: "…treatment initiation decreased…"

Distribution of non-pharmacological treatment related to insomnia disorder (2002–2019). حسب Mingee Choi (15250732)

الموضوعات: "…treatment initiation decreased…"

Detailed treatment status of patients who did not receive non-pharmacological treatment at first diagnosis but received it later. حسب Mingee Choi (15250732)

الموضوعات: "…treatment initiation decreased…"

Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year. حسب Mingee Choi (15250732)

الموضوعات: "…treatment initiation decreased…"

General information of patient who diagnosis insomnia disorder (N = 518,119). حسب Mingee Choi (15250732)

الموضوعات: "…treatment initiation decreased…"

Detailed treatment status of people who received non- pharmacological treatment at first diagnosis. حسب Mingee Choi (15250732)

الموضوعات: "…treatment initiation decreased…"

Treatment at first diagnosis of insomnia disorder (%). حسب Mingee Choi (15250732)

الموضوعات: "…treatment initiation decreased…"